Mariner

Mariner’s Myriad Genetics MYGN Stock Holding History

Mariner’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$233K	Buy	51,892 +3,726	+8%	+$19.4K	﹤0.01%	3068
2025 Q4	$296K	Buy	48,166 +19,522	+68%	+$142K	﹤0.01%	2859
2025 Q3	$207K	Buy	28,644 +16,794	+142%	+$99.7K	﹤0.01%	3147
2025 Q2	$62.9K	Buy	+11,850	New	+$70K	﹤0.01%	3313
2024 Q4	–	Sell	-17,490	Closed	-$479K	–	3476
2024 Q3	$479K	Buy	17,490 +621	+4%	+$16.8K	﹤0.01%	2157
2024 Q2	$412K	Buy	16,869 +1,206	+8%	+$26.5K	﹤0.01%	2192
2024 Q1	$334K	Buy	15,663 +837	+6%	+$18K	﹤0.01%	2349
2023 Q4	$284K	Sell	14,826 -869	-6%	-$15K	﹤0.01%	2398
2023 Q3	$252K	Sell	15,695 -1,188	-7%	-$22.6K	﹤0.01%	2308
2023 Q2	$391K	Sell	16,883 -1,636	-9%	-$35.7K	﹤0.01%	1918
2023 Q1	$430K	Buy	18,519 +864	+5%	+$17.5K	﹤0.01%	1784
2022 Q4	$256K	Sell	17,655 -1,877	-10%	-$35K	﹤0.01%	2161
2022 Q3	$373K	Buy	19,532 +5,051	+35%	+$116K	﹤0.01%	1618
2022 Q2	$263K	Buy	14,481 +154	+1%	+$3.2K	﹤0.01%	1318
2022 Q1	$361K	Buy	+14,327	New	+$367K	﹤0.01%	1237

Other funds holding MYGN

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Glenview Capital Management New York $3.69B AUM 20.52% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return